August 5, 1988 |
The Food and Drug Administration on Thursday gave approval for a drug that is the most widely prescribed anti-arthritis medication outside the United States. More than 64 million prescriptions were written worldwide last year for diclofenac sodium, which has the trade name Voltaren. But U.S. doctors had not been authorized to prescribe the drug pending the outcome of FDA-monitored clinical trials, which have been completed.
November 4, 2002 |
People with arthritis who take glucosamine have said it makes their joints feel better, and some studies have confirmed these reports. Now a three-year study at the Prague Institute of Rheumatology has confirmed that glucosamine appears to stop the narrowing of the space in the knee joint that typically occurs with arthritis.
May 4, 1998 |
Joan Poe felt the first symptoms of arthritis in 1962, at a time when physicians typically advised people with the disease to avoid exercise in an attempt to "save their joints." Whenever the pain in her knees got bad, Poe would put her feet up and rest.
CALIFORNIA | LOCAL
January 28, 1999
A new drug called etanercept can dramatically reduce the painful symptoms experienced by the more than 2 million Americans who suffer from rheumatoid arthritis, according to a study in today's New England Journal of Medicine. Researchers from Brigham and Women's Hospital in Boston gave 89 volunteers who suffered from long-term rheumatoid arthritis twice-weekly injections of the drug or a placebo in addition to their regular methotrexate treatments.
CALIFORNIA | LOCAL
July 17, 1997 |
A new drug that breaks the cycle of inflammation is showing promise against the crippling effects of rheumatoid arthritis. Results of a study with the medicine, which blocks a natural substance known as tumor necrosis factor, are being published in today's New England Journal of Medicine. More than 2 million Americans, mostly women, suffer from rheumatoid arthritis, a chronic inflammatory disease that causes pain, swelling, stiffness and loss of function in the joints.
March 8, 1990 |
Ciba-Geigy, a Swiss-based drug and chemicals manufacturer, has awarded UC San Diego's School of Medicine a $20-million grant to study the causes of arthritis, a disease that afflicts 37 million Americans. The agreement will fund a 50-person research team led by Dr. Dennis Carson, who is leaving Scripps Clinic & Research Foundation to join UCSD.
December 17, 2001 |
Question: I have arthritis in my toes and sometimes my hands and elbows, too. I try to walk for exercise, but when my toes get really sore, this isn't easy. Do you have any alternatives for exercise with arthritis? PATRICK WILTON Winter Park, Fla. Answer: Your walking routine is a great low-impact exercise for someone with arthritis, but when you have a flare-up in your toes, opt for a stationary bicycle.
October 6, 2000 |
The drug maker ESI Lederle announced Thursday that it is recalling 4.2 million capsules of the arthritis drug etodolac because they are contaminated with another drug that could cause life-threatening problems in some patients. The manufacturer said the recall covers one lot--No. 9991052--of 300-milligram capsules of the drug used in arthritis and pain management. The capsules were distributed nationwide.
CALIFORNIA | LOCAL
February 29, 2004 |
Sore and creaky, eight arthritis sufferers were wheeled into operating rooms at Hollywood Presbyterian Medical Center on Saturday morning to receive knee and hip replacements -- on the house. The patients had no hassles with insurance companies, nor were there squirmy visits with the hospital's billing office. The nonprofit Operation Walk Southern California and the hospital donated the surgeries and all associated costs, including follow-up care and physical therapy.
December 19, 1999 |
Norm Bass started as a pitcher for the Kansas City Athletics in 1964 and wound up as a defensive back for the Denver Broncos the same year. Bass was trying to be Bo Jackson and Deion Sanders before there was a Nike around to make Bass a millionaire or cultural icon. Bass was just a tall, muscular, quick, strong, talented athlete who was, it turns out, competing at only 60% efficiency.